
Butterfly Network, Inc.
BFLYNYSEHealthcareMedical - Devices
Previous close
$9.55
+$0.38 · +4.14%
BFLY company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
56
Fair Value
Momentum
71
Gaining
Sentiment
51
Mixed
Risk resilience
43
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteButterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Joseph DeVivo
- Listed since
- Jul 13, 2020
- Employees
- 220
Market position
Day range
Current $9.55
52-week range
Current $9.55
- Open
- $9.30
- Previous close
- $9.17
- Volume
- 5.71M
- 0.76× average
- Average volume
- 7.47M
- Average daily volume
- Market cap
- 2.54B USD
- Beta
- 2.08
- Market reference 1
- 50-day average
- $7.805
- +22.36% above average
- 200-day average
- $4.8568
- +96.63% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 808.98M USD
- P/E (TTM)
- -33×
- P/B (TTM)
- 13.22×
- P/S (TTM)
- 22.68×
- EV / EBITDA
- -12.01×
- Earnings yield
- -8.21%
- Free cash flow yield
- -1.71%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 52.64%
- Operating margin
- -70.79%
- Net margin
- -66.74%
- Return on equity
- -39.32%
- Return on assets
- -25.99%
- Return on invested capital
- -36.91%
Financial health
- Debt / equity
- 0.1×
- Current ratio
- 3.83×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 97.61M USD | 82.06M USD | 65.9M USD | 73.39M USD | 62.57M USD |
| Cost of goods sold | 51.88M USD | 33.23M USD | 49.04M USD | 33.93M USD | 45.51M USD |
| Gross profit | 45.73M USD | 48.83M USD | 16.86M USD | 39.46M USD | 17.05M USD |
| Research and development | 36.26M USD | 37.8M USD | 55.62M USD | 88.04M USD | 74.46M USD |
| Selling, general, and administrative | 85.11M USD | 85.44M USD | 106.85M USD | 144.44M USD | 135.32M USD |
| Operating expenses | 132.15M USD | 123.24M USD | 162.47M USD | 232.48M USD | 209.78M USD |
| Interest income | 5.91M USD | 5.02M USD | 7.45M USD | 3.38M USD | 2.57M USD |
| Interest expense | 1.49M USD | 1.26M USD | — | 2K USD | 651K USD |
| Depreciation and amortization | 8.08M USD | 10.34M USD | 10.57M USD | 5.94M USD | 2.09M USD |
| Operating income | −86.42M USD | −74.41M USD | −145.61M USD | −193.02M USD | −192.73M USD |
| Net income | −77.06M USD | −72.49M USD | −133.7M USD | −168.72M USD | −32.41M USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest fiscal-year EPS
- -0.31
- FY2025
- Latest fiscal-year revenue
- 97.61M USD
- FY2025 · +18.96% year over year
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$5.50
42.41% downsideBFLY peers
ETFs holding BFLY
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM49.11M0.06%81.62B USD0.19%$299.96+0.77%
ARK Genomic Revolution ETFARKG43.37M2.28%1.56B USD0.75%$49.45+3.80%
Vanguard Morningstar Total Stock Market ETFVTI42.55M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 Growth ETFIWO17.82M0.12%15.16B USD0.24%$387.37+1.24%
Vanguard Extended Market ETFVXF17.5M0.02%93.7B USD0.05%$245.53+0.82%
Fidelity Enhanced Small Cap ETFFESM15.21M0.23%6.03B USD0.28%$47.94+0.80%
Schwab U.S. Small-Cap ETFSCHA9.45M0.04%23.1B USD0.03%$34.83+0.52%
iShares U.S. Medical Devices ETFIHI9.33M0.27%3.49B USD0.37%$56.17+1.30%
iShares Russell 2000 ETFIWM- Market value
- 49.11M
- Weight
- 0.06%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
ARK Genomic Revolution ETFARKG- Market value
- 43.37M
- Weight
- 2.28%
- AUM
- 1.56B USD
- Expense ratio
- 0.75%
- Price / 1D
- $49.45+3.80%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 42.55M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 Growth ETFIWO- Market value
- 17.82M
- Weight
- 0.12%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37+1.24%
Vanguard Extended Market ETFVXF- Market value
- 17.5M
- Weight
- 0.02%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
Fidelity Enhanced Small Cap ETFFESM- Market value
- 15.21M
- Weight
- 0.23%
- AUM
- 6.03B USD
- Expense ratio
- 0.28%
- Price / 1D
- $47.94+0.80%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 9.45M
- Weight
- 0.04%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.83+0.52%
iShares U.S. Medical Devices ETFIHI- Market value
- 9.33M
- Weight
- 0.27%
- AUM
- 3.49B USD
- Expense ratio
- 0.37%
- Price / 1D
- $56.17+1.30%
Continue in GoAI
Research BFLYresearch.disclaimer





